Caricamento...
Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...
| Autori principali: | , , |
|---|---|
| Natura: | Online Articolo testo |
| Lingua: | English |
| Pubblicazione: |
Dove Medical Press
2014
|
| Soggetti: | |
| Accesso online: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918234/ https://www.ncbi.nlm.nih.gov/pubmed/27471700 http://dx.doi.org/10.2147/ITT.S40121 |